Northwestern Mutual Wealth Management
RXII

Northwestern Mutual Wealth Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,000
Closed -$10K – 2401
2015
Q4 		$10K Buy
+7,000
New +$10K ﹤0.01% 1180

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northwestern Mutual Wealth Management's RXII Position: Q1 2016 in Review

Northwestern Mutual Wealth Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2016, closing a stake of 7,000 shares — an estimated $10K sold.

Northwestern Mutual Wealth Management first reported a position in RXII in Q4 2015 and held it in 1 quarter. The position peaked at $10K in Q4 2015. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.

  • Northwestern Mutual Wealth Management reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 7,000 GALENA BIOPHARMA INC COM shares in Q1 2016, an estimated $10K.
  • Northwestern Mutual Wealth Management first reported a position in GALENA BIOPHARMA INC COM in Q4 2015 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's GALENA BIOPHARMA INC COM position peaked at $10K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.